CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.020
-0.160 (-5.03%)
Jun 5, 2026, 1:48 PM EDT - Market open
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $657.46 million as of June 5, 2026. Its market cap has increased by 295.82% in one year.
Market Cap
657.46M
Enterprise Value
348.44M
1-Year Change
295.82%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $657.46M, an increase of 8,784.63%. That is a compound annual growth rate of 52.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 692.30M | -4.09% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 715.42M |
| Oculis Holding AG | 714.39M |
| Solid Biosciences | 712.78M |
| Allogene Therapeutics | 704.12M |
| Alto Neuroscience | 702.11M |
| Candel Therapeutics | 679.22M |
| Design Therapeutics | 672.04M |
| CorMedix | 669.98M |